To establish the procedure to discontinue the distribution and sale of a batch of a product and retrieve (Recalled) unsold stock of the batch under question from the market promptly and effectively.
SCOPE
This procedure is applicable for drug products manufactured by Company Name for domestic as well as Export markets.
RESPONSIBILITY
Head- Quality Assurance
To investigate defective drug products and implement corrective action and preventive action.
To co-ordinate the recall by providing the required Details.
Disposition of the recalled Product.
ACCOUNTABILITY
Tech Director
- To receive and assess reports of suspected defective drug products.
- To advise and monitor necessary actions and recall and reconciliation.
- To communicate with relevant agencies
PROCEDURE
Definition:
Defective drug product
During the manufacturing or distribution of a drug product, an error or incident may occur whereby the drug product does not conform to its specification or is for some other reason defective (e.g. presence of a contaminant that may not be detected during routine analysis). Such a defect may impair the therapeutic effect of the product and could adversely affect the health of the patient.
Withdrawal:
The drug products are taken back from the market.
Recall:
Removal of a specific batch (es) of the drug product.
Recall decision:
Drug products shall be recalled in case of forced recall (can be due to Instruction from Regulatory or health authorities).
Voluntary recall:
Voluntary recall may be due to the following reason(s)
- Product Mix-ups
- Non-conforming results of ongoing stability study
- Labeling errors
- Damage of containers/closures holding the products during storage/transit
- Excess supply to the customers
- Market complaint
- Expired Product
- Minimizing the regulatory involvement
- Any other reasons
The Tech Director shall nominate the person for initiating an investigation, coordination, and product recall.
- An investigation for the correctness of reported defects shall be carried out independently by the Head-QA, Head-Production supported by Head-Marketing and Distribution.
- The investigation shall cover but not limited to:
- The control sample (Inspection and if required analysis)
- Stability study data
- Transpiration, Distribution & Storage
- Consumption & usage by user
- Pre and Post batches manufactured
- Product with the same formulation type
- Same product with different strengths
- In case of either of recall (forced or Voluntary) Tech director shall assess the situation/complaint / Instruction.
Classification of Recall
Based on the investigation data, the Head QA shall categorize the recall:
Class-I
The defect presents a life-threatening or serious risk to health.
Class –II
The defect may cause mistreatment or harm to the patient, but it is not life-threatening.
Class-III
The defect is unlikely to cause harm to the patient, and the recall is carried out for other reasons, such as non-compliance with the marketing authorization or specification.
Class IV
Where there is no threat to the patient or no serious defect likely to impair product use or efficacy. They are generally used for minor defects in packaging or other printed materials.
They can be called “Caution in use” defects.
For investigation and further action following details shall be made available by the concerned department head, agency, and personnel authorities.
- Product details
- Brand name
- Strength
- Pack size
- Batch No. / Lot No.
- Manufacturing date / Expiry date
- Any other details identifying the product/batch
- Mfg license No.
- Actual sample pack or photocopy
- Nature of defect
- The Tech Director and Head – QA shall jointly investigate the defect concerning:
- Nature and genuineness of defect.
- Causes of the defect (if not clearly identified probable cause).
- As and when required head QA shall seek the details, data, and documents from Location, Regulatory, Marketing and Distribution and other concerned departments.
- Based on the investigation, Head-QA shall suggest for classification of product recall.
- Product recall shall be initiated in case of justified reasons like:
- The drug product proves to be harmful under normal conditions of use.
- The drug product is lacking in therapeutic efficacy.
- The qualitative and quantitative composition of the product is not as declared.
- The control on the drug product and/or on the ingredients and the controls at an intermediate stage of the manufacturing process has not been carried out or if some other requirement or obligation relating to the grant of the manufacturing authorization has not been fulfilled.
- Head- QA shall forward the observations and suggestions for a product recall to the Director/Tech. Director.
- Once the product recall is authorized by the director/Tech. The director and head–QA nominated for the product recall shall inform head- of marketing and distribution to:
- Discontinue distribution/sale of products. Retrieve unsold stock from the market and under transit.
- Action to be taken (within the time frame/ immediately) to quarantine stock/ return stock.
- Both objectives shall be served by sending suitable communication to company distributors, wholesalers, field staff, and agents through by Head- of marketing and distribution.
- Records of distribution shall be used for sending recall notifications as per Annexure-II.
- For Domestic Recall- The distribution details of the batch shall be available from the distribution record(hardcopy/software as applicable). For a reconciliation of other batches, data can be available from the record of distribution depot stock, plant warehouse stock from electronic software, and WIP stock from BPR.
- For recall by contract Givers- Distribution details of the batch will be available to Contract givers through their own system. If information is received from the Contract giver for reconciliation of other batches, data can be available from the record of depot stock, plant warehouse stock from electronic software, WIP stock, from bath manufacturing record.
Recall notification shall include:
Recall details
- Nature of recall
- Recall class-I/II/III/IV
- Level of recall (distributor level, retail level, pharmacy, user level)
- Reason for recall
- Date of recall or withdrawal
Volume of recall
- Quantity manufactured
- The quantity consumed/ retained / underhold
- Quantity Distributed
- Estimated quantity in the market (distributor level, retail level, pharmacy, user level)
Product Details
- Brand name
- Strength
- Pack size
- Batch No. / Lot No.
- Manufacturing date
- Expiry date
- Any other details identifying the product/ batch
- Product license (PL Number), if applicable
- Packing details (Product labeling)
- Actual sample pack or photocopy
- Promotional material(if applicable)
- Nature of defect.
- Details of defects
- Direction of use/ Route of administration
- The account of any action taken in consequence
Recalling firm details
- Name(s) of firm
- Contact person along with contact number (office hours and off hours)
- Firm address, city, state, country, zip code
Distribution details (names/address/city/state/contact name/phone number)
- Wholesalers
- Distributors
- Re-packers
- Retail/pharmacy/veterinarian,
- Users/customers, (medical, hospitals, clinics, laboratories)
- Government Consignee
- Foreign consignees (specify whether they are wholesale distributors, retailers or users)
- Geographic areas of distribution, including foreign countries.
- Head- QA shall be forward all the above details to all concerned personnel, authorities, agencies, and departments through mail, fax, telephone or by any other means
Recall Strategy:
Based on observation, investigation and above information Head-QA shall decide the recall Strategy.
The strategy shall include
- Method of notification
- Notification to Regulatory Agency/ Authority(Local/ Export Country)
- Notification to contract giver
- Mechanism of recall
- Impact on the consumer(if this recall will create a market shortage that will)
- Recall effectiveness check
- The course of action for out-of-business distributors
- Possible ways of addressing the defect
- Disposition of Recalled Product
- Head Marketing and distribution (Local/Export) shall immediately arrange to freeze All stocks of the Specified Product/ Batch lying with distributors, agents, and Customers.
- Head Market shall also instruct the entire sales force to freeze the further sale of product/batch at every distribution, sales point (stockiest, chemist, doctors, Hospitals etc.) This also shall include goods under transit.
- Head Marketing and distribution shall send a product recall circular immediately upon receiving the product recall notification to all concerned persons requesting them to all stock of the product / Batch under question to the depots and informing them that a credit note for the stocks returned shall be issued to them at the earliest.
0 Comments